• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Cellebrite Appoints Thomas E. Hogan as Executive Chairman of the Board

    8/8/23 7:00:00 AM ET
    $CLBT
    Computer Software: Prepackaged Software
    Technology
    Get the next $CLBT alert in real time by email

    Seasoned Technology Leader to Partner with CEO Yossi Carmil to Further Company Growth and Strategic Priorities

    TYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Cellebrite DI Ltd. (NASDAQ:CLBT), a global leader in Digital Intelligence (DI) solutions for the public and private sectors, announced today that proven industry veteran, Thomas E. Hogan has been appointed Executive Chairman of the Board.

    Based in Austin, Texas, Hogan brings a remarkable 40+ year track record of exceptional shareholder returns, client impact, and employee growth. He has significant expertise in strategic M&A, sales and marketing, international operations, and talent acquisition and development. During his career Tom has led numerous acquisitions totally nearly $8B including marquis targets such as Mercury Interactive and Opsware. His career includes over a decade as both a private and publicly held software CEO as well as senior executive posts ranging from late stage private to mega-cap public companies.

    "Tom's experience will be invaluable as we scale Cellebrite, extend our market leading digital intelligence solutions, and ultimately enable justice across the globe. I am excited to partner closely with Tom as we navigate our next chapter of growth and global impact," said Yossi Carmil, CEO, Cellebrite.

    "I look forward to my new partnership with Yossi, Haim Shani and the entire Cellebrite board, and the talented men and women across Cellebrite, as we build upon the impressive momentum of the company. I am especially enthused about the mission-driven purpose of this organization and our opportunity to better equip law enforcement and judicial systems worldwide," said Thomas E. Hogan, Executive Chairman of the Board.

    Hogan previously served as chairman and CEO of Kony, Inc, President and CEO of Vignette (VIGN), executive vice president of sales and marketing for Hewlett Packard, executive vice president of software for HP, executive vice president of CSC, chief sales officer at Siebel Systems, and most recently as a Operating Managing Director at Vista Equity Partners. He has held numerous public and private board positions including directorships at Citrix, Gainsight, Pluralsight, Drift, Vignette, Kony, Vastera, and Inforte. Tom holds a Masters in Management from Northwestern University and a B.S. in Biomedical Engineering from the University of Illinois.

    Cellebrite's current non-executive chairman, Haim Shani, will remain an active member of the board. Haim will leverage his extensive experience as the former CEO of NICE, the former Director General of the Israel Ministry of Finance, and his current role as founder and general manager of Israel Growth Partners, to further strengthen contributions from the Cellebrite board.

    "On behalf of the entire Cellebrite board, I am pleased to welcome Tom to the Cellebrite team. Getting to know Tom as the head of the search committee and working with Yossi the past four years, I believe their combined strengths deliver the best leadership team in the industry. While I am passing the torch of chairman duties to Tom, I will continue to contribute as an active member of the Cellebrite board and look forward to working closely with Tom and the Cellebrite management team as we continue our journey," said Haim Shani, former Cellebrite chairman.

    About Cellebrite

    Cellebrite's (NASDAQ:CLBT) mission is to enable its customers to protect and save lives, accelerate justice, and preserve privacy in communities around the world. We are a global leader in Digital Intelligence solutions for the public and private sectors, empowering organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes.

    Trusted by thousands of leading agencies and companies worldwide, Cellebrite's Digital Intelligence platform and solutions transform how customers collect, review, analyze and manage data in legally sanctioned investigations. To learn more visit us at www.cellebrite.com, https://investors.cellebrite.com, or follow us on Twitter at @Cellebrite.

    Caution Regarding Forward-Looking Statements

    This document includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as "forecast," "intend," "seek," "target," "anticipate," "believe," "could," "continue," "expect," "estimate," "may," "plan," "outlook," "future" and "project" and other similar expressions that predict, project or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements include estimated financial information. Such forward-looking statements with respect to revenues, earnings, performance, strategies, prospects, and other aspects of the business of Cellebrite are based on current expectations that are subject to risks and uncertainties. A number of factors could cause actual results or outcomes to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to: Cellebrite's ability to develop technologically advanced solutions and successfully integrate with the software solutions used by customers; acceptance of solutions by customers; errors, failures, defects or bugs in solutions; a failure to maintain sales and marketing personnel productivity or hire, integrate and retain additional sales and marketing personnel; the impact of the global COVID-19 pandemic; the impact of competition on pricing and on Cellebrite's market share; sub-optimal results from products due to misuse by customers; Cellebrite's failure to maintain and enhance its reputation and brand; inaccuracy of the estimates of Cellebrite's market opportunity and forecasts of market growth; changes to packaging and licensing models that adversely affect the ability to attract or retain customers; failure to manage future growth effectively; failure to introduce new solutions and add-ons; issues in the use of artificial intelligence resulting in reputational harm or liability; the need for additional capital to support the growth of Cellebrite's business; a failure to maintain the security of operations and the integrity of software solutions; the impact of government budgeting cycles and appropriations, early termination, audits, investigations, sanctions and penalties; a decline in government budgets, changes in spending or budgetary priorities, or delays in contract awards; a failure to adequately obtain, maintain, protect and enforce Cellebrite's intellectual property or infringement of the intellectual property rights of others; perceptions or court or regulatory decisions that Cellebrite's solutions violate privacy rights; the use of solutions by customers in a way that is, or that is perceived to be, incompatible with human rights; failure to comply with laws regarding privacy, data protection and security, technology protection, sanctions, export controls and other matters; and other factors, risks and uncertainties set forth in the sections titled "Risk Factors" and "Cautionary Note Regarding Forward-Looking Statements" in our Annual Report on form 20-F filed with the SEC on March 29, 2022 and in other documents filed by Cellebrite with the U.S. Securities and Exchange Commission ("SEC"), which are available free of charge at www.sec.gov. You are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made, in this communication or elsewhere. Cellebrite undertakes no obligation to update its forward-looking statements, whether as a result of new information, future developments, or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws. 

    Cellebrite Contacts

    Media

    Victor Cooper

    Sr. Director of Corporate Communications + Content Operations

    [email protected]

    +1 404.804.5910

    Investors

    Andrew Kramer

    VP, Investor Relations

    [email protected]

    +1 973.206.7760

    A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/774b7b9d-8b12-4bd0-9ff6-ad1b46feb3e0



    Primary Logo

    Get the next $CLBT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CLBT

    DatePrice TargetRatingAnalyst
    3/28/2024$13.00 → $13.50Buy
    Needham
    3/13/2024Mkt Perform → Outperform
    William Blair
    2/16/2024$9.00 → $12.00Neutral → Buy
    BofA Securities
    7/19/2023$11.00Buy
    Craig Hallum
    8/12/2022$6.50 → $6.00Buy → Neutral
    BofA Securities
    8/12/2022Outperform → Mkt Perform
    William Blair
    2/24/2022$10.50Overweight
    JP Morgan
    2/11/2022$10.50Buy
    Deutsche Bank
    More analyst ratings

    $CLBT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by Cellebrite DI Ltd.

      SC 13D/A - Cellebrite DI Ltd. (0001854587) (Subject)

      9/17/24 4:33:52 PM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology
    • Amendment: SEC Form SC 13D/A filed by Cellebrite DI Ltd.

      SC 13D/A - Cellebrite DI Ltd. (0001854587) (Subject)

      8/29/24 6:07:01 PM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology
    • SEC Form SC 13G/A filed by Cellebrite DI Ltd. (Amendment)

      SC 13G/A - Cellebrite DI Ltd. (0001854587) (Subject)

      3/12/24 12:38:56 PM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology

    $CLBT
    Leadership Updates

    Live Leadership Updates

    See more
    • Cellebrite Appoints Michael D. Capellas to Board of Directors as Lead Independent Director

      TYSONS CORNER, Va. and PETAH TIKVA, Israel, Jan. 06, 2025 (GLOBE NEWSWIRE) --  Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced a series of Board updates to support the Company's continued growth into 2025 and beyond. As previously detailed on November 6, 2024, Thomas E. Hogan has been appointed interim CEO to begin 2025 as part of a planned leadership transition. In conjunction with stepping into this position, Mr. Hogan remains on the Company's Board of Directors and plans to revert to his position as chairman upon the eventual appointment of a new CEO. As part of Cellebrite's ongoing commitment to

      1/6/25 8:00:00 AM ET
      $CLBT
      $CSCO
      Computer Software: Prepackaged Software
      Technology
      Computer Communications Equipment
      Telecommunications
    • Yossi Carmil to Step Down as CEO After Nearly 20 Years

      TYSONS CORNER, Va. and PETAH TIKVA, Israel, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced a planned leadership transition following Yossi Carmil's decision to step down from his current role as CEO and as a member of the Board of Directors by December 31, 2024. The Board has initiated a formal search for a new CEO, retaining an executive recruiting firm to advance this effort. Thomas E. Hogan, Cellebrite's executive chairman, will serve as interim CEO upon Carmil's departure and until the search is complete and a new CEO joins Cellebrite. "Cellebrite is indebted to

      11/6/24 8:20:00 AM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology
    • Cellebrite Appoints Tech Veteran Troy K. Richardson to Board of Directors

      TYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier digital investigative solutions for the public and private sectors, announced today that Troy Richardson has joined its board of directors, effective August 13, 2024. Mr. Richardson is a seasoned technology executive with more than 30 years of experience in leading, scaling and transforming global organizations. He currently serves on the Unisys Corporation (NYSE:UIS) Board of Directors and previously served as a Director of the Board for Carestream Dental. Mr. Richardson was president of the Digital Thread group at PTC Inc. (NASDAQ:PTC) from 2021 until 2022

      8/14/24 7:00:00 AM ET
      $CLBT
      $PTC
      $UIS
      Computer Software: Prepackaged Software
      Technology
      EDP Services

    $CLBT
    Financials

    Live finance-specific insights

    See more
    • Cellebrite to Report First-Quarter 2025 Financial Results on May 14, 2025

      TYSONS CORNER, Va. and PETAH TIKVA, Israel, April 10, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced it will report its first-quarter 2025 financial results before market open on Wednesday, May 14, 2025. Later that same morning, Cellebrite will host a live conference call and webcast to review the Company's financial results for the first quarter of 2025 and discuss its full-year 2025 outlook. Relevant details include: Date:Wednesday, May 14, 2025Time:8:30 a.m. ETCall-In Number:203-518-9783 / 800-267-6316Conference ID:CLBTQ125Event URL:https://investors.cellebrite.com/events/

      4/10/25 8:30:00 AM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology
    • Cellebrite Announces Fourth-Quarter and Full-Year 2024 Results

      Company delivers "Rule of 50" Performance in 2024 with 25% ARR growth and 25% adjusted EBITDA margin Fourth-quarter 2024 revenue of $109.0 million grew 17% primarily due to21% growth in subscription revenue ARR grew 25% to $395.9 million Fourth-quarter 2024 adjusted EBITDA of $28.8 million, 26.4% adjusted EBITDA margin TYSONS CORNER, Va. and PETAH TIKVA, Israel, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced financial results for the three and twelve months ending December 31, 2024. "Cellebrite delivered a solid fourth-quarter performance to cap an excellent 2024

      2/13/25 7:00:00 AM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology
    • Cellebrite to Report Fourth-Quarter and Fiscal Year 2024 Financial Results on February 13, 2025

      TYSONS CORNER, Va. and PETAH TIKVA, Israel, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced it will report its fourth-quarter and fiscal year 2024 financial results before market open on Thursday, February 13, 2025. Later that same morning, Cellebrite will host a live conference call and webcast to review the Company's financial results for the fourth quarter of 2024 and discuss its 2025 outlook. Relevant details include: Date:Thursday, February 13, 2025Time:8:30 a.m. ETCall-In Number:203-518-9783 / 800-267-6316Conference ID:         CLBTQ424Event URL:https://investor

      1/10/25 8:00:00 AM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology

    $CLBT
    SEC Filings

    See more
    • Amendment: SEC Form SCHEDULE 13D/A filed by Cellebrite DI Ltd.

      SCHEDULE 13D/A - Cellebrite DI Ltd. (0001854587) (Subject)

      3/20/25 4:30:03 PM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 20-F filed by Cellebrite DI Ltd.

      20-F - Cellebrite DI Ltd. (0001854587) (Filer)

      3/18/25 7:04:55 AM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 144 filed by Cellebrite DI Ltd.

      144 - Cellebrite DI Ltd. (0001854587) (Subject)

      2/28/25 4:04:55 PM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology

    $CLBT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Needham reiterated coverage on Cellebrite DI with a new price target

      Needham reiterated coverage of Cellebrite DI with a rating of Buy and set a new price target of $13.50 from $13.00 previously

      3/28/24 8:25:08 AM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology
    • Cellebrite DI upgraded by William Blair

      William Blair upgraded Cellebrite DI from Mkt Perform to Outperform

      3/13/24 7:29:30 AM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology
    • Cellebrite DI upgraded by BofA Securities with a new price target

      BofA Securities upgraded Cellebrite DI from Neutral to Buy and set a new price target of $12.00 from $9.00 previously

      2/16/24 7:23:02 AM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology

    $CLBT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Cellebrite Unveils Spring 2025 Release to Accelerate Global Investigations

      TYSONS CORNER, Va. and PETAH TIKVA, Israel, May 06, 2025 (GLOBE NEWSWIRE) --  Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced its Spring 2025 Release, featuring a new cloud foundation and AI-powered innovations across its portfolio. These enhancements are already playing an important role in helping customers modernize their digital workflows, speed up their investigations and elevate operational productivity and efficiency. The Spring 2025 Release introduces the Cellebrite Cloud, which delivers a purpose-built user experience that scales investigative capabilities and accelerates decision-making acro

      5/6/25 8:30:00 AM ET
      $AMZN
      $CLBT
      Catalog/Specialty Distribution
      Consumer Discretionary
      Computer Software: Prepackaged Software
      Technology
    • Cellebrite to Report First-Quarter 2025 Financial Results on May 14, 2025

      TYSONS CORNER, Va. and PETAH TIKVA, Israel, April 10, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced it will report its first-quarter 2025 financial results before market open on Wednesday, May 14, 2025. Later that same morning, Cellebrite will host a live conference call and webcast to review the Company's financial results for the first quarter of 2025 and discuss its full-year 2025 outlook. Relevant details include: Date:Wednesday, May 14, 2025Time:8:30 a.m. ETCall-In Number:203-518-9783 / 800-267-6316Conference ID:CLBTQ125Event URL:https://investors.cellebrite.com/events/

      4/10/25 8:30:00 AM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology
    • 10 Winners Awarded "Justies" at Cellebrite's First-Ever Digital Justice Awards

      TYSONS CORNER, Va. and PETAH TIKVA, Israel, April 01, 2025 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ:CLBT), a global leader in Digital Investigative (DI) solutions for the public and private sectors, awarded ten winners "Justies" at the Company's inaugural Digital Justice Awards. Held at The National Law Enforcement Museum in Washington, DC, Cellebrite rolled out the orange carpet to celebrate some of the brightest minds and sharpest technical skillsets in digital investigations. "It was inspiring to celebrate those who tirelessly protect their communities," said Tom Hogan, Cellebrite's chief executive officer. "The evening shined a bright light on the courage, passion and dedication of thes

      4/1/25 8:30:00 AM ET
      $CLBT
      Computer Software: Prepackaged Software
      Technology